Clinical characteristics of COVID-19 patients who underwent tracheostomy and its effect on outcome: A retrospective observational study

doi:10.5501/wjv.v11.i6.477

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1818)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

106

WORD

HTML

816

Tables (1-2)

119

Sum=1071

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

210

Download

537

Sum=747

Nov 25, 2022 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Virol. Nov 25, 2022; 11(6): 477-484
Published online Nov 25, 2022. doi: 10.5501/wjv.v11.i6.477

Table 1 Clinical-demographic parameters of COVID-19 patients who underwent tracheostomy

Characteristics	n = 73
Age (yr)	52 ± 16.67
Male	38 (52%)
Female	35 (48%)
Comorbities & COVID related complications n (%)
HTN	26 (35.6%)
DM	18 (24.66%)
CAD	04 (5.44%)
CKD with AKI	25 (34.3%)
CVA	11 (15.1%)
TBI	02 (2.74%)
Stroke	05 (6.8%)
Pneumothorax	10 (13.7%)
Mucormycosis	06 (8.22%)
Shock	44 (60.2%)
COVID severity n (%)
Mild	14 (19.2%)
Moderate	22 (30.2%)
Severe	37 (50.6%)
Initial respiratory support n (%)
RA	9 (12.3%)
FM	6 (8.2%)
NRBM	14 (19.2%)
HFNC	8 (10.9%)
NIV	5 (6.8%)
MV	31 (42.5%)
Tracheostomy related events (mean ± SD)
Admission to tracheostomy (d)	18.12 ± 12.98
Intubation to tracheostomy (d)	11.97 ± 9
ICU stay (d)	25 ± 11
Hospital stay (d)	28.21 ± 11.60
Death (n, %)	52 (71.2%)
Discharge (n, %)	21 (28.8%)

HTN: Hypertension; DM: Diabetes mellitus; CAD: Coronary artery disease; CKD with AKI: Chronic kidney disease with acute kidney injury; CVA: Cerebrovascular accident; TBI: Traumatic brain injury; RA: Room air; FM: Face mask; NRBM: Non-rebreathing mask; HFNC: High-flow nasal cannula; NIV: Non-invasive ventilation; MV: Mechanical ventilation.

Citation: Singh Y, Soni KD, Singh A, Choudhary N, Perveen F, Aggarwal R, Patel N, Kumar S, Trikha A. Clinical characteristics of COVID-19 patients who underwent tracheostomy and its effect on outcome: A retrospective observational study. World J Virol 2022; 11(6): 477-484
URL: https://www.wjgnet.com/2220-3249/full/v11/i6/477.htm
DOI: https://dx.doi.org/10.5501/wjv.v11.i6.477